Athanor Capital’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-207,037
Closed -$17.6M 866
2020
Q3
$17.6M Buy
207,037
+185,869
+878% +$9.4M 0.67% 51
2020
Q2
$750K Buy
+21,168
New +$619K 0.04% 240

Athanor Capital's IMMU Position: Q4 2020 in Review

Athanor Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 207,037 shares — an estimated $17.6M sold.

Athanor Capital first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $17.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Athanor Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Athanor Capital sold 207,037 Immunomedics Inc shares in Q4 2020, an estimated $17.6M.
  • Athanor Capital first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Athanor Capital's Immunomedics Inc position peaked at $17.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.